ABSTRACT. Azoxymethane (AOM) administration followed by repetitive dextran sulfate sodium (DSS) ingestion causes chronic colonic inflammation with macrophage infiltration and enhanced expression of a macrophage-tropic chemokine, CCL2, in wild-type (WT) mice. These mice eventually develop multiple colon tumors. In contrast, mice deficient in CCR2, a specific receptor for CCL2, exhibited less macrophage infiltration and attenuated tumor formation. WT mice transplanted with CCR2-deficient bone marrow developed fewer tumors after AOM and DSS treatment than either WT or CCR2-deficient mice transplanted with WT bone marrow. Furthermore, when injected to WT mice with multiple colon tumors, a CCL2 antagonist expression vector attenuated macrophage and granulocyte infiltration, and eventually reduced the numbers and sizes of tumors. These results implied the crucial involvement of the CCL2-CCR2 interactions in the development and progression of colon carcinoma associated with chronic inflammation.
INTRODUCTION
Ulcerative colitis (UC) is an inflammatory bowel disease, characterized by repetitive relapses and remissions, which can cause epithelial dysplasia and can progress to invasive cancer. Thus, long-standing UC is a predisposing factor for colon cancer development. The combined administration of a carcinogen, azoxymethane (AOM) and dextran sulfate sodium (DSS) to rodents is widely employed in order to recapitulate colon cancer associated with chronic inflammation such as UC. DSS causes extensive mucosal inflammatory reaction in the colon, and a prior AOM administration accelerates development of colon carcinomas. In this AOM/DSS-induced colon carcinogenesis, massive intracolonic infiltration of macrophages is consistently observed and is presumed to have a crucial role. Monocyte chemoattractant protein-1 (MCP-1)/CCL2 is a chemokine which regulates the migration and activation of monocytes/macrophages. It exerts its effects through binding to its specific receptor, CCR2. Accumulating evidence indicates the role of the CCL2/CCR2 axis in various chronic inflammatory diseases, and in cancer pathobiology. To explore the role of CCL2/CCR2 axis in AOM/DSSinduced colon carcinogenesis, we used CCR2-deficient mice and the gene delivery of an N-terminal deletion mutant of human CCL2 (7ND), which effectively inhibits CCL2 in vivo [1] . Our experiments revealed that the CCL2/CCR2 interactions induced the recruitment of cyclooxygenase (COX)-2-expressing inflammatory cells, leading to colon cancer development.
METHODS

Animal experiments
Pathogen-free 8-to 12-week old female wild-type BALB/c mice (WT) and CCR2-1 -mice were injected intraperitoneally with 12 mg/kg body weight of AOM (Sigma-Aldrich; Inc., St. Louis, MO) dissolved in physiological saline. Five days later, 2 % DSS (MW 36,000-50,000; MP Biochemicals Inc., Aurora, OR) was given in the drinking water over five days, followed by 16 days of regular water. This cycle was repeated a total of 3 times (Fig. 1A) . In another series of experiments, human 7ND-expressing-or pcDNA3 vector were injected into the femoral muscle of WT mice at day 56, followed by electroporation with an electrical pulse generator (ECM830; BTX, San Diego, CA) (Fig. 4A) • --I x 10 7 bone marrow cells, after being irradiated with 4.25 Gy X-rays followed by 4.25 Gy X-rays (MPR-1520R; Hitachi) 4 hours later. The following groups of chimeric mice were generated; WT to WT, WT to CCR2-I., CCR2-I. to WT, and CCR2-I-to CCR2-I-mice. Quantitative RT-PCR analysis Real-Time PCR was performed on Applied Biosystems
Step Orie" Real-Time PCR System using the comparative C T quantitaion method. TaqMan® Gene Expression Assays (Applied Biosystems, Foster City , CA), containing specific primers (accession numbers : MCP-I/CCL2 -Mm00441242 ml , KC /CXCLlStatistical analysis The mean±S .D. were calculated for all parameters determined. Statistical significance was evaluated using one-way analysis of variance (ANOVA), and p values lower than 0.05 were considered statistically significant.
RESULTS
Enhanced CCL2 expression in the colon during the course of colon carcinogenesis A single intraperitoneal injection of the carcinogen AOM, followed by 3 rounds of 2% DSS intake, induced the development of multiple tumors in the middle to distal colon of WT mice (Fig . IB, C) . Because we previously observed a massive infiltration of macrophages during the course of this colon carcinogenesis process [2] , we investigated the expression of the macrophage-tropic chemokine MCP-I /CCL2 and its specific receptor, CCR2. CCL2 mRNA expression level was negligible in untreated WT mice , but DSS intake augmented it (Fig .  ID) . CCL2 protein was detected in mononuclear cell s infiltrating into lamina propria and submucosal regions , endothelial cells at the earlier phase and colon carcinoma cell s at the later pha se (data no shown). CCR2 wa s expre ssed by mononuclear cell s infiltrating the lamina propria and submucosa, and in some colon carcinoma cells during the course of this colon carcinogene sis (data not shown). (Fig . I E, F) . At days 28 to 35 , adenocarcinomatous lesions with nuclear~-catenin accumulation appeared in the pre senc e of macrophage and granulocyte infiltration , and their sizes and number s increased progressively, ther eafter (Fig. IB, C) . On the contrary, CCR2-' -mice displayed mild inflammatory changes in the colon during the course of DSS intake as evi denced by attenuated infiltration of macrophages and granulocytes (Fig. IE, F) and eventually developed few adenocarcinomatous lesions with less nuclear~ catenin accumulation (Fig. IB, C) . These observations implied the CCL2/CCR2 interactions as crucial for the development of chron ic inflammation-associated colon carcinoma development. Contrib utio n of CCR2-expressi ng bo ne marrowde rived cells to colon carcinogenesis Because CCR2 is expressed by non-bone marrow-as we ll as bone marrow-derived cells, we explored the contribution of CCR2-e xpressing non-bone marrow-and bone marrow-derived cell s to this colon carcinogenesis by using bone marrow chimer ic mice prepared between WT and CC R2-'-mice . Upon the combined treatment with AOM and DSS, CCR2 -' -and WT mice transplanted with WT mouse -deri ved bone marrow cells , developed tumors to similar but at a higher level than either WT or CCR2 -' -mice transplanted with CCR2-' -mouse-derived bone marrow (Fig. 2 ). These observation s would indicate that CCR2-expressing bone marrow-derived cells but not non-bone marrow -derived cells were mainly responsible for tumor development in this model.
Re d uctio n in AOM /DSS
-i n d uce d inflam mato ry reactio n a n d subseq ue nt tu mor fo rmatio n in t he absence of CCR2 Consistently, microscopical analysis demons trated that WT mice developed severe inflammation in the middle to distal colon at day 7. At day 14, inflammatory cell infiltration persisted, accompanied with dysplastic glands (d ata not shown) . Moreover, immunohistochemical analy si s demonstrated that infl ammatory cell s con sisted of F4/80-positive macrophages and Ly6G -positi ve granulocytes
Reduction in AOM/DSS-induced expression of COX-2 in CC R2-
-mice
Mirror ing the crucial roles of C O X-2 in colon carcinogenesis , COX-2 mRNA expre ssion and COXexpressing cell number were increased in WT mice later than 7 days after the initi ati on of DSS treatment (Fig.  3) , as we previously observed [2] . AOM/DSS-induced increas es in COX-2 mRN A ex press ion and COX-2 -positive cell numbers , were depressed in the absence of CCR2 (Fig. 3A, C) . Collectivel y, AOM /DSS failed to increase the expression ofCOX-2 in CCR2-' -mice. were treated with 7ND-expres sing vector, the numb ers and sizes of macroscopical tumors were markedly reduced (Fig. 4B, C) . Concomitantl y, the treatment with 7ND-expressing vector decrea sed the numbers of infiltrating macrophages and neutrophils (Fig. 4D, E) . Moreover, 7ND administration reduced intracolonic COX-2 mRNA expression and COX-2 expressing cell numbers ( Fig.  4F and data not shown) . Moreover, 7ND treatment decreased intratumoral CD31-positive vascular area s significantly (Fig. 4G, H) . Furthermore, 7ND treatment decreased~-catenin nucl ear accumulation in the tumor cells (Fig. 41) and cytokeratin 20-po sitive cell numbers (data not shown). Collectively, these observations would indicate that the CCR2/CCL2 interaction s were crucially involved even in the pro gression phas e after multiple tumors de veloped, by regulating COX-2-express ing inflammatory cell infiltration.
DISCUSSION
Accumulating evidence sugg ests that the CCL2/CCR2 axis plays important roles in the pathogenesis of various diseases by regulating the infiltration of macrophages. Inde ed , the intramuscular transduction of the mut ant MCP-l gene, 7ND, MCP-l inhibitor, inhib ited vascular remodeling in rat s [1] , ath ero sclerosis progression in mice [3] , and am eliorated renal ischemia-reperfus ion injury and renal fibrosis in mice [4, 5] . Thus, 7ND may effectively block CCL2 /CCR2 signa ling and pla ya protective role in related diseases.
Chemokines contribut e to tumor growth and progression and CCL2 is reported to be expressed by a variety of cancer types. CCL2 may exert its tumor promoting effects by recruiting macrophages, which are major sources of growth and angiogenic factors. Once secreted from colon adenoma cell s, CCL2 can stimulate COX -2 expression, as well as PGE z and VEGF release from hum an macrophages [6] . Simultaneously, CCL2 can exe rt grow th stimulating effects on CCR2-express ing tumor cells in an autocrine manner. In addition, CCL2 has been reported to possess proangiogeni c activity on CCR2-expressing endothelial cells [7] . In thi s study we dem onstrated that CCL2 producti on was enhanced during the course of AOM/DSS-induced colon carcinogen esis. Moreover, blockin g of the CC L21 CCR2 signaling could attenuate colon tumorigenesis by decreasing the numbers of infiltrating COX-2-expressing macrophag es and neutroph il s, leading to redu ced neo vascularization and~-cat enin acti vation . Thus, targeting the CCL2/CCR2 axis may prove beneficial for patients with inflammation-associated cancers. 
